Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Salit

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Ethics|July 1, 1997
Stability of treatment preferences: although most preferences do not change, most people change some of their preferencesN Kohut, M Sam, K O'Rourke, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 12, 2001
HIV pharmacy specialty residency program in CanadaA Tseng, M Foisy, J Bajcar, et al.
AIDS Research and Human Retroviruses|February 1, 1995
Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infectionW K Chia, J Freedman, X Li, et al.
Viral Immunology|January 1, 1994
Lack of correlation between phenotype activation markers of CD8 lymphocytes and cytotoxic T lymphocyte (CTL) function in HIV-1 infection: evidence for rescue with rIL-2W K Chia, E Nisbet-Brown, X Li, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndromeS Walmsley, C Levinton, J Brunton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1997
Mycobacterium xenopi infection in patients with human immunodeficiency virus infectionP el-Helou, A Rachlis, I Fong, et al.
The Journal of Infectious Diseases|March 1, 1988
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)S L Walmsley, E Chew, S E Read, et al.
International Journal of STD & AIDS|April 20, 2000
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.
International Journal of Dermatology|November 30, 2000
Epidemiology and prevalence of onychomycosis in HIV-positive individualsA K Gupta, P Taborda, V Taborda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1997
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study GroupP Phillips, S Shafran, G Garber, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Ethics|July 1, 1997
Stability of treatment preferences: although most preferences do not change, most people change some of their preferencesN Kohut, M Sam, K O'Rourke, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 12, 2001
HIV pharmacy specialty residency program in CanadaA Tseng, M Foisy, J Bajcar, et al.
AIDS Research and Human Retroviruses|February 1, 1995
Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infectionW K Chia, J Freedman, X Li, et al.
Viral Immunology|January 1, 1994
Lack of correlation between phenotype activation markers of CD8 lymphocytes and cytotoxic T lymphocyte (CTL) function in HIV-1 infection: evidence for rescue with rIL-2W K Chia, E Nisbet-Brown, X Li, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndromeS Walmsley, C Levinton, J Brunton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1997
Mycobacterium xenopi infection in patients with human immunodeficiency virus infectionP el-Helou, A Rachlis, I Fong, et al.
The Journal of Infectious Diseases|March 1, 1988
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)S L Walmsley, E Chew, S E Read, et al.
International Journal of STD & AIDS|April 20, 2000
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.
International Journal of Dermatology|November 30, 2000
Epidemiology and prevalence of onychomycosis in HIV-positive individualsA K Gupta, P Taborda, V Taborda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1997
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study GroupP Phillips, S Shafran, G Garber, et al.
Pageof 3